Nov 11, 2020 / 10:00PM GMT
Operator
Good afternoon, and welcome to Oncolytics Biotech's Third Quarter 2020 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Jon Patton, Director of Investor Relations and Communications. Please go ahead.
Jon Patton -
Thank you, Jason. Good afternoon, everyone, and welcome to Oncolytics Biotech's Third Quarter 2020 Conference Call. Earlier today, Oncolytics issued a press release providing financial results and corporate updates for the third quarter of 2020. A replay of today's call will be available on the Investors and Media section of the Oncolytics website approximately 2 hours after its completion. After remarks from company management, we will open the call for Q&A.
As a reminder, various remarks made during this call contain certain forward-looking statements relating to the company's business prospects and the development and commercialization of pelareorep, including statements regarding the company's focus, strategy and objectives,
Q3 2020 Oncolytics Biotech Inc Earnings Call Transcript
Nov 12, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers